Loading clinical trials...
Loading clinical trials...
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Evommune, Inc.
NCT06229834 · Episodic Migraine
NCT06603558 · Chronic Migraine, Episodic Migraine, and more
NCT05987592 · Migraine
NCT07103694 · Episodic Migraine, Chronic Migraine, and more
NCT06616194 · Migraine
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions